checkAd
    Startseite > Aktien > Nanobiotix > Nachrichten
    Nanobiotix Aktie
    5,6450
     
    EUR
    -13,35 %
    -0,8700 EUR
    Letzter Kurs 16:41:00 Tradegate
    5,7100
     
    EUR
    600 STK
    Geldkurs 17:29:03
    5,7700
     
    EUR
    600 STK
    Briefkurs 17:29:03
    ISIN: FR0011341205 · WKN: A1J7EB · SYM: 5NR · Frankreich

    Neueste Nachrichten

    NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
    08:00 Uhr · globenewswire · Nanobiotix
    Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
    21.05.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    16.05.24 · globenewswire · Nanobiotix
    NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
    15.05.24 · globenewswire · Nanobiotix
    NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
    14.05.24 · globenewswire · Nanobiotix
    NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
    24.04.24 · globenewswire · Nanobiotix
    NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
    17.04.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    10.04.24 · globenewswire · Nanobiotix
    Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
    02.04.24 · globenewswire · Nanobiotix
    Nanobiotix to Present at Upcoming Investor Conferences in March
    06.03.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    13.02.24 · globenewswire · Nanobiotix
    Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
    31.01.24 · globenewswire · Nanobiotix